Nexplanon side effects by duration, gender and age - a phase IV clinical study of FDA data
Summary:
Side effects are reported by people who take Nexplanon. Common side effects include complication of device insertion among females, and foetal exposure during pregnancy among males.
The phase IV clinical study is created by eHealthMe based on 44,811 reports from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
44,811 people who take Nexplanon and have side effects are studied.
What is Nexplanon?
Nexplanon has active ingredients of etonogestrel. It is used in birth control. Currently, eHealthMe is studying from 45,519 Nexplanon users.
Number of Nexplanon reports submitted per year:
Nexplanon side effects by time on the drug *:
Nexplanon side effects by gender *:
Nexplanon side effects by age *:
* Approximation only. Some reports may have incomplete information.
Do you take Nexplanon?
Personalize this study to your gender and ageHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How the study uses the data?
The study is based on etonogestrel (the active ingredients of Nexplanon) and Nexplanon (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.
Related studies
Alternative drugs to, pros and cons of Nexplanon:
- Nexplanon (45,519 reports)
Common Nexplanon side effects:
- Heavy or prolong menstrual bleeding: 2,527 reports
- Weight increased: 1,827 reports
- Vaginal bleeding: 1,649 reports
All Nexplanon side effects from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zWho is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Docetaxel and Malaise - now
- Lupron and Diarrhea Aggravated - 4 seconds ago
- Mometasone Furoate and Psychiatric Symptom - 5 seconds ago
- Tafinlar and Blood Sodium Decreased - 5 seconds ago
- Prozac and Duodenal Ulcer Aggravated - 14 seconds ago
- Singulair and Colonoscopy Abnormal - 18 seconds ago
- Percocet and Photosensitivity Reaction - 19 seconds ago
- Inflectra and Bruxism - 21 seconds ago
- Isosorbide Dinitrate and Hepatotoxicity Aggravated - 26 seconds ago
- Clotrimazole and Sudafed 12 Hour drug interaction - 30 seconds ago